NVO
Novo Nordisk A/S
37.30$
-0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in DKK.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.02 | 7.42 | 9.53 | 8.31 | 9.20 | 9.83 | 11.10 | 11.94 | 17.36 | 24.23 | 27.10 | 26.78 | |
| 0.65 | 0.57 | 0.63 | 0.64 | 0.81 | 1.19 | 1.23 | 1.31 | 1.62 | 2.09 | 4.28 | 4.94 | |
| 0.07 | 0.09 | 0.07 | 0.06 | 0.09 | 0.08 | 0.18 | 0.23 | 0.34 | 0.48 | 0.51 | – | |
| 0.75 | 0.00 | 2.15 | 0.70 | 1.12 | 1.42 | 1.90 | 2.30 | 4.87 | – | – | – | |
| -0.41 | -0.42 | -0.73 | -0.73 | -0.70 | -0.71 | -0.93 | -1.88 | -1.17 | -2.72 | 0.58 | 0.84 | |
| 0.82 | 1.24 | 1.63 | 1.74 | 2.56 | 2.36 | 4.72 | 1.60 | 3.25 | 8.65 | 11.50 | 20.26 | |
| -0.39 | -1.18 | -1.34 | -1.33 | -2.49 | -2.42 | -4.79 | -6.86 | -5.48 | -9.77 | -28.88 | -17.80 | |
| 2.26 | 2.50 | 4.70 | 3.80 | 3.93 | 4.08 | 4.30 | 4.67 | 5.57 | 7.07 | 9.89 | 11.64 | |
| -2.79 | -3.33 | -2.97 | -3.40 | -3.21 | -3.22 | -3.60 | -4.22 | -5.30 | -6.66 | -4.52 | -0.31 | |
| – | 0.00 | 0.02 | 0.02 | 0.02 | -0.16 | 1.01 | 3.36 | -0.53 | -0.33 | 16.37 | 5.56 | |
| -5.04 | -5.84 | -7.67 | -7.20 | -7.12 | -7.46 | -6.89 | -5.53 | -11.40 | -14.05 | 1.96 | -6.39 | |
| 0.60 | 0.42 | 0.51 | -0.26 | -0.32 | -0.05 | -0.68 | -0.33 | 0.43 | 0.39 | 0.28 | 2.43 | |
| 5.20 | 6.18 | 7.90 | 6.56 | 6.64 | 7.47 | 6.38 | 10.34 | 14.11 | 15.58 | 15.61 | 6.52 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.